Insulet Analyst Price Targets - Benzinga

Insulet Corp

PODDNASDAQ

Trade with Public

Trade with Public

$133.68

0.420.32%

Last update: Aug 6, 10:43 AM

PRO

Why Is It Moving?™:Insulet shares are trading lower after the company reported Q2 financial re...

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Insulet Analyst Price Targets

Wall Street analyst price targets and consensus rating for Insulet (PODD).

Price Target Range — 8 Quarters

Analyst Consensus — 24 Analysts

17Buy

6Hold

1Sell

Consensus RatingBuy# Analysts24Avg. Consensus PT$266Upside to Avg. PT+98.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 6, 2026	Stifel	Jonathan Block	PT Cut	Buy	$225→$180
Aug 6, 2026	Wells Fargo	Lawrence Biegelsen	Downgrade	Overweight→Equal-Weight	$255→$144
Aug 6, 2026	JP Morgan	Robbie Marcus	Downgrade	Overweight→Neutral	$275→$152
Aug 6, 2026	BTIG	Marie Thibault	Downgrade	Buy→Neutral	—
Aug 6, 2026	Truist Securities	Richard Newitter	Downgrade	Buy→Hold	$210→$153
Jul 28, 2026	UBS	Patrick Wood	Assumes	Buy→Neutral	$174
Jul 13, 2026	Truist Securities	Richard Newitter	PT Cut	Buy	$219→$210
Jul 13, 2026	RBC Capital	Shagun Singh	PT Cut	Outperform	$280→$245
Jul 10, 2026	Stifel	Jonathan Block	PT Cut	Buy	$250→$225
Jul 8, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$165→$172
Jul 6, 2026	Evercore ISI Group	Daniel Markowitz	PT Cut	Outperform	$200→$180
Jun 23, 2026	Deutsche Bank	Kieran Ryan	Initiate	Buy	$190
Jun 12, 2026	Truist Securities	Richard Newitter	PT Cut	Buy	$250→$219
May 28, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$175→$165
May 27, 2026	RBC Capital	Shagun Singh	Maintained	Outperform	$280
May 27, 2026	BTIG	Marie Thibault	PT Cut	Buy	$260→$235
May 20, 2026	William Blair	Steve Lichtman	Assumes	Outperform	—
May 18, 2026	B of A Securities	Travis Steed	PT Cut	Buy	$288→$208
May 8, 2026	Barclays	Matt Miksic	PT Cut	Underweight	$286→$198
May 7, 2026	Canaccord Genuity	William Plovanic	PT Cut	Buy	$435→$249

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Stifel Maintains Buy on Insulet, Lowers Price Target to $180

Stifel analyst Jonathan Block maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $225 to $180.

Benzinga Newsdesk

Paycom Software To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Thursday

Analysts changed outlook on top names: JP Morgan cut price target for Insulet, HC Wainwright slashed EyePoint's target, Goldman cut Sunrun's, B of A lowered Coupang's, BTIG cut Klaviyo's, Jefferies raised J&J Snack Foods', Raymond James raised Select Water Solutions', and Freedom Broker raised Danaos'.

Avi Kapoor

This HubSpot Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. HUBS, PODD, FRPT, WTTR, REXR downgraded.

Avi Kapoor

These Analysts Slash Their Forecasts On Insulet After Q2 Results

Insulet Corp. (NASDAQ:PODD) reported strong Q2 earnings but lowered revenue outlook for 2021. Analysts downgraded stock and lowered price targets.

Avi Kapoor

PRO
Wells Fargo Downgrades Insulet to Equal-Weight, Lowers Price Target to $144

Wells Fargo analyst Lawrence Biegelsen downgrades Insulet (NASDAQ:PODD) from Overweight to Equal-Weight and lowers the price target from $255 to $144.

Benzinga Newsdesk

PRO
JP Morgan Downgrades Insulet to Neutral, Lowers Price Target to $152

JP Morgan analyst Robbie Marcus downgrades Insulet (NASDAQ:PODD) from Overweight to Neutral and lowers the price target from $275 to $152.

Benzinga Newsdesk